Pyxis Oncology Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Pyxis Oncology stock has a consensus rating of "Strong Buy" and an average price target of $8.88. The average 1-year stock price forecast is 390.33% higher than the current stock price, while the lowest is $7.00 (+286.74%) and the highest is $19 (+949.72%).

Price Target: $8.88 (+390.33%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$7.00	$8.88	$7.50	$19
Change	+286.74%	+390.33%	+314.36%	+949.72%

Analyst Ratings

The average analyst rating for Pyxis Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	8	7	7	8	8	8
Buy	1	1	1	1	1	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	9	9	10	10	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Derek Archila Wells Fargo	Wells Fargo	Buy Reiterates $19	Buy	Reiterates	$19	+949.72%	Oct 16, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $6	Buy	Maintains	$6	+231.49%	Oct 9, 2026
Swayampakula Ramakanth H.C. Wainwright	H.C. Wainwright	Buy Reiterates $8	Buy	Reiterates	$8	+341.99%	Oct 1, 2026
Sam Slutsky LifeSci Capital	LifeSci Capital	Buy Maintains $6 → $8	Buy	Maintains	$6 → $8	+341.99%	Sep 26, 2026
Andy Hsieh William Blair	William Blair	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Sep 9, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

19.44K

from 13.86M

-99.86%

from 13.86M

Revenue Next Year

2.78M

from 19.44K

14,188.99%

from 19.44K

EPS This Year

-1.21

from -1.28

EPS Next Year

-1.11

from -1.21

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	16.15M	13.86M	19.44K
Revenue Growth	-	-	-	-	-14.17%	-99.86%
Operating Income	-69.72M	-123.48M	-80.42M	-65.57M	-81.85M	-100.63M
Net Income	-75.98M	-120.72M	-73.79M	-77.33M	-79.62M	-94.39M
EPS	-	-	-	-	-1.28	-1.21
Free Cash Flow	-	-	-	-	-	-101.10M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	175,000
Avg	19,440
Low	n/a

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	-98.7%
Avg	-99.9%
Low	-100.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.99
Avg	-1.21
Low	-1.49

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-